8-K
filed September 12, 2024, 7:59 PM ET
ticker CNSP
CIK 0001729427
regulatory
confidence high
sentiment positive
materiality 0.60
CNS Pharma regains Nasdaq compliance; subject to one-year Mandatory Panel Monitor
CNS Pharmaceuticals, Inc.
- On Sep 10, 2024, Nasdaq confirmed CNS Pharma has demonstrated compliance with the $2.5M stockholders' equity requirement; delisting matter closed.
- Company is subject to a Mandatory Panel Monitor for one year; if non-compliance recurs, immediate delist with no cure period.
- Previous extensions from Aug 2023 to Aug 2024 to regain compliance; now resolved with heightened monitoring.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001683168-24-006318
- form_type
- 8-K
- ticker
- CNSP
- cik
- 0001729427
- company_name
- CNS Pharmaceuticals, Inc.
- filed_at
- 2024-09-12T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:14.337539+00:00
- generated_at
- 2026-05-31T05:15:30.851622+00:00
- sec_items
- ["3.01"]
- event_type
- regulatory
- sentiment
- positive
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001683168-24-006318
- json_url
- https://secwatch.observer/filing/0001683168-24-006318.json
- markdown_url
- https://secwatch.observer/filing/0001683168-24-006318.md
- text_url
- https://secwatch.observer/filing/0001683168-24-006318.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1729427/000168316824006318/0001683168-24-006318-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1729427/000168316824006318/cns_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
GENC
Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing
GENCOR INDUSTRIES INC
June 1, 2026, 4:09 PM ET
regulatory
Items 3.01, 7.01, 9.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
NUTR
NusaTrip receives Nasdaq delinquency notice for late 10-K and 10-Q; faces delisting if not compliant by Oct 12, 2026
NUSATRIP Inc
June 1, 2026, 7:10 AM ET
regulatory
Items 3.01, 9.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
XXI
Twenty One Capital receives NYSE non-compliance notice; audit committee lacks independence; cure due June 5
Twenty One Capital, Inc.
June 1, 2026, 7:05 AM ET
regulatory
Items 3.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
COLA
Columbus Acquisition regains compliance with Nasdaq $50M MVLS rule; delisting risk removed
Columbus Acquisition Corp/Cayman Islands
May 29, 2026, 9:56 PM ET
regulatory
Items 3.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
CSAI
Cloudastructure receives Nasdaq delinquency notice for late Q1 10-Q filing
CLOUDASTRUCTURE, INC.
May 29, 2026, 5:09 PM ET
regulatory
Items 3.01, 9.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
CETY
Clean Energy Technologies receives Nasdaq delisting notice for late Q1 filing
Clean Energy Technologies, Inc.
May 29, 2026, 4:57 PM ET
regulatory
Items 3.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
GURE
Gulf Resources receives Nasdaq delisting notice for late Q1 2026 10-Q filing
GULF RESOURCES, INC.
May 29, 2026, 4:45 PM ET
regulatory
Items 3.01, 9.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
FTHM
Fathom Holdings receives Nasdaq notice for late Q1 2026 10-Q filing; 60 days to submit plan
Fathom Holdings Inc.
May 29, 2026, 4:15 PM ET
regulatory
Items 3.01, 9.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.